SYNCELL Inc. announced today that it will unveil its novel spatial proteomics system, Microscoop™, at the upcoming American Association for Cancer Research (AACR) 2022 Annual Meeting, which will be held April 8 - 13 in New Orleans, Louisiana. SYNCELL will showcase the Microscoop system, and the spatial biomarker discovery data it has generated from various subcellular and cellular locations by combining the use of AI pattern recognition and its novel photolabeling chemistries. SYNCELL will also present a poster on applying this multidisciplinary technology platform for cancer research.
SYNCELL’s Microscoop platform is not just a microscopy imager for studying the immunostaining pattern of dozens of selected proteins. Microscoop combines the optoproteomics technology with SYNCELL’s novel photoreactive chemistry to image and “scoop up” the selected subcellular structures in a biospecimen for whole proteome analysis. This unique system will expand the horizons of spatially resolved biomarker discovery in many fields of biology. The resulting contextual proteomics data can lead to the identification of novel biomarkers and unveil previously unknown cellular interactions and functions to help deduce new biological mechanisms, identify new drug targets and discover diagnostic biomarkers for therapy response or disease progression.
"We are excited to share our latest novel biomarker discovery data that demonstrate our spatial biology platform can identify previous unknown proteins in a targeted location," said Dr. Jung-Chi Liao, CEO of SYNCELL. "We believe cancer researchers and therapy developers will find the data both interesting and empowering. I want to invite the AACR attendees to visit our booth and discuss ideas on using Microscoop to accelerate their proteomics applications.”
The poster and booth related details are highlighted below:
Poster Title: De novo spatial proteomic profiling of immune synapses using machine learning-guided Microscoop
Session Title: Models and Technical Approaches to Analyze and Examine the Tumor Microenvironment
Poster Number: 3875
Poster Session Time: April 13 from 9:00 AM to 12:30PM
Booth Number: 823
About Syncell Inc.
SYNCELL is a near-commercial stage life science startup, with a vision to revolutionize spatial biology research. Founded in 2020 by Jung-Chi Liao, PhD, SYNCELL is developing its Microscoop™ platform based on the optoproteomics technology Dr. Liao invented at Academia Sinica in Taiwan. The company has offices in both Taipei City and Silicon Valley. Its first product, Microscoop, is the first and only microscopic imaging system that allows researchers to pick up, identify and quantify thousands of known and unknown proteins in specified cellular and subcellular locations. SYNCELL currently offers global customers early access to Microscoop technology through its customer service program GRASP (Global Rapid Access Service Program). Microscoop will provide deep spatial proteomics insights to transform a wide range of basic biology and translational research including neuroscience, oncology, immunology, or infectious disease to identify novel biomarkers with spatial context to accelerate biomarker discovery research and drug development programs. Learn more.
Contact:
Shuyi Liao
Syncell, Inc.
Phone +886-2-77505632
Info@syncell.com
Follow SYNCELL on LinkedIn at SYNCELL INC. and tag your posts with #syncell or #microscoop